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Dear Editor:
The number of articles presenting a neurosurgical prediction
model is rapidly increasing [1]. Although the number of pub-
lications reporting a clinical prediction model in Child’s
Nervous System, Journal of Neurosurgery Pediatrics, and
Pediatric Neurosurgery is relatively constant over the years
(Fig. 1a), circa two-thirds of these publications have been
published since 2015 (Fig. 1b). Nowadays, with the rise of
so many prediction models, we should be able to make firm
conclusions which model to use on our patients.
Clinical prediction models aim to predict an outcome of
interest, for example, survival in high-grade glioma (HGG)
patients or intraventricular hemorrhage in preterm infants, by
combining two or more patient-related variables. The obtained
predictions of these models can then be used for medical and
shared decision-making such as initiating surgical treatment,
and for example for guidance in planning future lifestyle.
The development and evaluation of clinical prediction
models involve multiple methodological steps. It is well-
known that these steps are often inadequately addressed and/
or inadequately reported in a publication which clearly limits
the usefulness of the presented prediction model. Utilizing
invalid prediction models may jeopardize adequate decision-
making in our daily clinical practice. Therefore, we want to
point out a few crucial aspects of prediction models.
1. Sample size—In clinical prediction model studies, the
number of events in the study population defines the ef-
fective sample size. As a rule of thumb, the minimum
required number of 10 events per prognostic variable
considered has been generally accepted; although recent-
ly, more advanced calculations have been proposed which
may yield a different ratio. The number of events is the
smaller of the number of patients having the event or not
having the event. Thus, if in a set of 110 HGG patients, 50
HGG patients died during the study period, considering
up to 5 prognostic variables seems reasonable for the de-
velopment of a prediction model. Considering too many
prognostic variables increases the risk of overfitting [2].
Overfittedmodels show promising results when evaluated
on the patients on which the model was developed but
show disappointing results when applied to other sets of
patients. This point is essential because many pediatric
neurosurgical studies have relatively low effective sample
sizes.
2. Validation—It is vital to gauge the validity of the predic-
tions provided by a prediction model. As a result of
overfitting, prediction models tend to have a too optimis-
tic predictive performance in terms of discrimination and
calibration [2]. Internal validation aims to quantify this
optimism. These techniques reuse the same set of patients
on which the model was developed. This step is a mini-
mum requirement for publication of a prediction model.
External validation assesses the performance of the pre-
diction model on a different set of patients, for example,
collected at other geographical locations and/or time pe-
riods. External validation is imperative before a clinical
uptake of the proposed model can take place.
3. Reporting—Guidelines for reporting prediction models
do exist. The TRIPOD (transparent reporting of a multi-
variable prediction model for individual prognosis or di-
agnosis) guideline together with its explanatory paper
provides crucial information for the design, conduction,
and evaluation of a prediction model [3, 4]. It is highly
recommended to adhere to the items of the TRIPOD
checklist for proper and transparent reporting. Often
graphical presentations of the underlying statistical model
are provided in a publication, but (statistical) details are
lacking. For example, when Cox regression is used for
predicting survival, the regression coefficients and the
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baseline survival at a given timepoint should be reported
to enable external validation.
We encourage the journal and its readers to critically
review studies on prediction models. Published work does
not always provide sufficient details of the model, al-
though this is necessary to judge the quality of the pre-
diction model. More details of the presented methodolog-
ical concerns and others including the selection of candi-
date prognostic variables and evaluating model perfor-
mance measures have been recently published and illus-
trated with clinical examples specifically for neurosur-
geons [1]. Furthermore, 7 key steps for the development
and evaluation of a neurosurgical clinical prediction mod-
el are tabulated for a quick overview. Pediatric neurosur-
geons should ideally be aware of this methodology as it is
highly consequential to our daily clinical practice.
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Fig. 1 a, b Time trends of the published number of pediatric neurosurgical
clinical prediction models according to the following systematic searches in
PubMed until December 31, 2019. For the black results: (Prognostic-
index* OR Prognostic-rule* OR Prognostic-model* OR prognostic-scor*
OR prediction-index* OR prediction-rule* OR prediction-model* OR
prediction-scor* OR predictive-index* OR predictive-rule* OR
predictive-model* OR predictive-scor*) AND (Neurosurgery [mh] OR
Neurosurgical Procedures [mh] OR Neurosurg* OR Neurological-surg*)
AND (“child”[mh] OR “Infant”[mh] OR “Adolescent”[mh] OR
“Minors”[mh] OR “Pediatrics”[mh] OR “Child Health Services”[mh] OR
“Hospitals, Pediatric”[mh] OR “Intensive Care Units, Pediatric”[Mesh] OR
infan*[tiab] OR newborn*[tiab] OR new born*[tiab] OR baby [tiab] OR
babies [tiab] OR neonat*[tiab] OR perinat*[tiab] OR postnat*[tiab] OR
prematur*[tiab] OR pre-matur*[tiab] OR child [mesh] OR child [tiab] OR
child’s [tiab] OR childhood*[tiab] OR children*[tiab] OR kid [tiab] OR
kids [tiab] OR toddler*[tiab] OR adoles*[tiab] OR teen*[tiab] OR
boy*[tiab] OR girl*[tiab] OR minors*[tiab] OR underag*[tiab] OR under
age*[tiab] OR under aging [tiab] OR under ageing [tiab] OR juvenil*[tiab]
ORyouth*[tiab] OR kindergar*[tiab] OR puber*[tiab] OR pubescen*[tiab]
OR prepubescen*[tiab] OR prepuberty*[tiab] OR pediatric*[tiab] OR
peadiatric*[tiab] OR schoolchild*[tiab] OR preschool*[tiab] OR
highschool*[tiab] OR suckling*[tiab] OR PICU [tiab] OR NICU [tiab]
OR PICUs [tiab] OR NICUs [tiab]). For the colored results: (Prognostic-
index* OR Prognostic-rule* OR Prognostic-model* OR prognostic-scor*
OR prediction-index* OR prediction-rule* OR prediction-model* OR
prediction-scor* OR predictive-index* OR predictive-rule* OR
predictive-model* OR predictive-scor*) AND (Neurosurgery [mh] OR
Neurosurgical Procedures [mh] OR Neurosurg* OR Neurological-surg*)
AND (“Childs Nerv Syst”[Journal] OR “Journal of Neurosurgery
Pediatrics”[Journal] OR “Pediatric Neurosurgery”[Journal])
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